生物訊號擷取系統市場規模、佔有率和成長分析：按組件、訊號類型、系統類型、應用、最終用戶、連接方式和地區分類 - 2026-2033 年產業預測

2024年全球生物訊號採集系統市值為5.489億美元，預計將從2025年的6.1916億美元成長到2033年的16.2284億美元。預測期（2026-2033年）的複合年成長率預計為12.8%。

全球生物訊號採集系統市場的發展動力源自於臨床和消費領域對精準、連續生理監測日益成長的需求。這些系統能夠擷取心電圖 (ECG)、腦電圖 (EEG) 和肌電圖 (EMG) 等多種生理訊號，從而實現診斷和遠端患者監護。早期發現並持續追蹤健康狀況可顯著降低住院率，並有助於制定個人化治療方案。在感測器技術進步的推動下，市場正從大型醫院級設備轉向緊湊型、基於雲端分析的無線設備。微型感測器與先進連接技術的融合正在推動市場擴張，催生出能夠提醒醫護人員注意危險狀況並改善診斷通訊協定的設備。此外，人工智慧透過先進的降噪和特徵提取技術提升訊號質量，最佳化數據分析，有助於改善醫療效果。

全球生物訊號擷取系統市場促進因素

遠端患者監護計畫的激增顯著推動了對生物訊號採集系統的需求，這些系統能夠在傳統醫院環境之外，實現生理數據的連續、非侵入性採集。醫療服務提供者正致力於開發能夠全面追蹤關鍵健康指標（例如心率、呼吸模式和電生理訊號）的技術，這些指標對於慢性病管理和降低再入院風險至關重要。為此，製造商正在不斷改進感測器整合、無線功能以及與各種臨床平台的兼容性等特性。這種對遠端醫療的關注正在拓展部署的可能性，加快採購流程，並推動對支持以患者為中心的醫療模式的靈活採集解決方案的投資。

全球生物訊號擷取系統市場的限制因素

全球生物訊號採集系統市場面臨許多挑戰，主要源自於醫療設備和軟體相關監管要求的複雜性和不斷變化。這些法規透過延長產品開發週期和增加遵循成本，對開發商構成了阻礙。製造商必須應對區域差異化的核准流程，遵守嚴格的資料安全和病患安全標準，並進行全面的臨床檢驗，以滿足監管機構和付款方的期望。此外，大量的文件工作，以及上市後監測和互通性測試的要求，可能會阻礙中小企業進入該市場，最終影響創新生物訊號擷取技術在臨床應用中的及時推廣。

生物訊號採集系統的全球市場趨勢

全球生物訊號採集系統市場正經歷著向穿戴式遠端監測解決方案的顯著轉變。這正推動著醫療模式向去中心化模式的根本性變革，該模式強調對病人的持續觀察。舒適性高的設備有助於提高用戶依從性，並能與遠距遠端醫療平台無縫整合，從而促進慢性病的積極管理和復健。醫療服務提供者與技術合作夥伴之間日益緊密的協作，正在推動可互通的醫療路徑的開發，這些路徑優先考慮患者體驗、安全的數據傳輸和遠端臨床決策支援。因此，這一趨勢正在促進生物訊號監測在臨床和消費市場中得到更廣泛的應用。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

市場考察

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場吸引力指數
• PESTEL 分析
• 監理情勢
• 技術分析

全球生物訊號擷取系統市場規模：按組件和複合年成長率分類（2026-2033 年）

• 硬體
  • 感測器和電極
  • 擴大機
  • 資料收集單元
  • 訊號調理裝置
• 軟體
  • 訊號處理軟體
  • 數據分析和視覺化軟體
• 服務

全球生物訊號擷取系統市場規模：按訊號類型和複合年成長率分類（2026-2033 年）

• 心電圖（ECG）
• 腦電圖（EEG）
• 肌電圖（EMG）
• 功能性近紅外線光譜（fNIRS）
• 腦磁圖（MEG）
• 眼電圖（EOG）
• 呼吸訊號
• 其他

全球生物訊號擷取系統市場規模：按系統類型和複合年成長率分類（2026-2033 年）

• 穿戴式裝置
  • 智慧型手錶
  • 穿戴式感測器
• 非穿戴式系統

全球生物訊號擷取系統市場規模：按應用和複合年成長率分類（2026-2033 年）

• 臨床診斷
• 病患監測
• 研究和學術用途
• 居家醫療
• 運動與健身監測
• 神經復健

全球生物訊號擷取系統市場規模：依最終用戶和複合年成長率分類（2026-2033 年）

• 醫院
• 專科診所
• 診斷檢查室
• 學術和研究機構
• 生物技術和製藥公司
• 居家醫療環境
• 運動健身中心

全球生物訊號擷取系統市場規模：連結方式、性別及複合年成長率（2026-2033）

• 有線系統
• 無線系統

全球生物訊號擷取系統市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 2023-2025年營收年比比較

主要企業簡介

• BioSignal Technologies
• Cognevo
• NeuroSky
• MEDLITE
• BioTrace
• BrainVision
• Thought Technology
• MindMedia
• Advantech
• VitalConnect
• Neuroelectrics
• Zeto
• BioSensics
• Emotiv
• g.tec medical engineering
• eVokai
• Nexus Bioengineering
• Aesculap Meditec
• Synapse Biomedical
• AliveCor

結論與建議

Global Biosignal Acquisition System Market size was valued at USD 548.9 Million in 2024 and is poised to grow from USD 619.16 Million in 2025 to USD 1622.84 Million by 2033, growing at a CAGR of 12.8% during the forecast period (2026-2033).

The global biosignal acquisition system market is driven by an increasing need for precise and continuous physiological monitoring in both clinical and consumer environments. These systems capture various physiological signals such as ECG, EEG, and EMG, facilitating diagnostics and remote patient monitoring. Early detection and ongoing tracking of health conditions significantly lower hospitalization rates and promote personalized treatment plans. The market has transitioned from bulky hospital apparatus to compact, wireless devices bolstered by cloud analytics, attributed to advancements in sensor technology. The fusion of miniaturized sensors and advanced connectivity propels market expansion, yielding devices that alert healthcare providers to critical conditions and refine diagnostic protocols. Furthermore, AI enhances signal quality through sophisticated noise reduction and feature extraction, thereby optimizing data analysis for improved healthcare outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biosignal Acquisition System market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biosignal Acquisition System Market Segments Analysis

Global biosignal acquisition system market is segmented by component, signal type, system type, application, end user, connectivity and region. Based on component, the market is segmented into Hardware, Software and Services. Based on signal type, the market is segmented into Electrocardiogram (ECG), Electroencephalogram (EEG), Electromyography (EMG), Functional Near-Infrared Spectroscopy (fNIRS), Magnetoencephalography (MEG), Electrooculography (EOG), Respiratory Signals and Others. Based on system type, the market is segmented into Wearable Devices and Non-Wearable Systems. Based on application, the market is segmented into Clinical Diagnostics, Patient Monitoring, Research & Academic Use, Home Healthcare, Sports & Fitness Monitoring and Neurorehabilitation. Based on end user, the market is segmented into Hospitals, Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, Homecare Settings and Sports & Fitness Centers. Based on connectivity, the market is segmented into Wired Systems and Wireless Systems. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biosignal Acquisition System Market

The surge in remote patient monitoring initiatives is significantly boosting the demand for biosignal acquisition systems, as they facilitate the continuous and noninvasive gathering of physiological data beyond traditional hospital settings. Healthcare providers are increasingly focused on technologies that enable comprehensive tracking of key health indicators, such as heart rate, breathing patterns, and electrophysiological signals, crucial for managing chronic diseases and minimizing the likelihood of readmissions. In response, manufacturers are enhancing aspects like sensor integration, wireless functionality, and compatibility with various clinical platforms. This heightened emphasis on remote care broadens deployment possibilities, accelerates purchasing processes, and fosters investment in flexible acquisition solutions that support patient-centered healthcare models.

Restraints in the Global Biosignal Acquisition System Market

The Global Biosignal Acquisition System market faces significant challenges due to complex and continuously changing regulatory requirements related to medical devices and software. These regulations create barriers for developers by prolonging the product development process and raising compliance expenses. Manufacturers must negotiate various approval processes in different regions, adhere to strict data security and patient safety standards, and conduct thorough clinical validation to meet the expectations of regulators and payers. Additionally, the extensive documentation needed, along with demands for post-market surveillance and interoperability testing, can discourage smaller companies, ultimately hindering the timely introduction of innovative biosignal acquisition technologies into clinical use.

Market Trends of the Global Biosignal Acquisition System Market

The Global Biosignal Acquisition System market is witnessing a significant trend towards wearable remote monitoring solutions, fundamentally transforming care delivery into a decentralized model that emphasizes continuous patient observation. This shift facilitates proactive management of chronic conditions and rehabilitation, as devices designed for comfort enhance user adherence and seamlessly integrate with telemedicine platforms. Increased collaboration between healthcare providers and technology partners is leading to the development of interoperable care pathways that prioritize patient experience, secure data transmission, and remote clinical decision support. Consequently, this trend is fostering broader acceptance of biosignal monitoring across both clinical settings and consumer markets.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Technology Analysis

Global Biosignal Acquisition System Market Size by Component & CAGR (2026-2033)

• Market Overview
• Hardware
  • Sensors & Electrodes
  • Amplifiers
  • Data Acquisition Units
  • Signal Conditioning Devices
• Software
  • Signal Processing Software
  • Data Analysis & Visualization Software
• Services

Global Biosignal Acquisition System Market Size by Signal Type & CAGR (2026-2033)

• Market Overview
• Electrocardiogram (ECG)
• Electroencephalogram (EEG)
• Electromyography (EMG)
• Functional Near-Infrared Spectroscopy (fNIRS)
• Magnetoencephalography (MEG)
• Electrooculography (EOG)
• Respiratory Signals
• Others

Global Biosignal Acquisition System Market Size by System Type & CAGR (2026-2033)

• Market Overview
• Wearable Devices
  • Smartwatches
  • Wearable Sensors
• Non-Wearable Systems

Global Biosignal Acquisition System Market Size by Application & CAGR (2026-2033)

• Market Overview
• Clinical Diagnostics
• Patient Monitoring
• Research & Academic Use
• Home Healthcare
• Sports & Fitness Monitoring
• Neurorehabilitation

Global Biosignal Acquisition System Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Clinics
• Diagnostic Laboratories
• Academic & Research Institutes
• Biotechnology & Pharmaceutical Companies
• Homecare Settings
• Sports & Fitness Centers

Global Biosignal Acquisition System Market Size by Connectivity & CAGR (2026-2033)

• Market Overview
• Wired Systems
• Wireless Systems

Global Biosignal Acquisition System Market Size & CAGR (2026-2033)

• North America (Component, Signal Type, System Type, Application, End User, Connectivity)
  • US
  • Canada
• Europe (Component, Signal Type, System Type, Application, End User, Connectivity)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Component, Signal Type, System Type, Application, End User, Connectivity)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Component, Signal Type, System Type, Application, End User, Connectivity)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Component, Signal Type, System Type, Application, End User, Connectivity)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• BioSignal Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cognevo
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroSky
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEDLITE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioTrace
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BrainVision
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thought Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MindMedia
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advantech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VitalConnect
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuroelectrics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zeto
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioSensics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emotiv
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• g.tec medical engineering
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• eVokai
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nexus Bioengineering
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aesculap Meditec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synapse Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AliveCor
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations